Literature DB >> 15573204

Subcutaneous dirofilariasis caused by Dirofilaria repens.

Rajan Chopra1, Bodh R Panhotra, Yusef Al-Marzooq, Abdul-Rahman Al-Mulhim.   

Abstract

Human dirofilariasis caused by Dirofilaria repens D. repens is a common zoonosis in the Mediterranean countries and parts of South Asia. During the last decade, it has been reported from countries previously considered non-endemic. This is likely due to the increased awareness regarding Dirofilaria infection. In some such cases however, dirofilariasis correlated with the travel of the patient to the endemic areas. We present the case of a Saudi male who had D. repens infection in the subcutaneous tissues of the forearm. The patient had traveled to Iraq, Syria, United Arab Emirates and Kuwait in the last 2 years. However, the known Dirofilaria endemic countries were not visited. Any prior occurrence of the human dirofilariasis in the Kingdom of Saudi Arabia is not documented. Lack of epidemiological studies or incidence reports in the Arabian region precludes any factual evaluation of Dirofilaria prevalence, which requires increased awareness amongst health workers regarding its potential occurrence in the native population.

Entities:  

Mesh:

Year:  2004        PMID: 15573204

Source DB:  PubMed          Journal:  Saudi Med J        ISSN: 0379-5284            Impact factor:   1.484


  3 in total

1.  Subconjunctival dirofilariasis: a case report from the United Arab Emirates and review of literature from the Arabian Gulf region.

Authors:  Nour Dababo; Amit Jain; Priti Joshi; Adnan Alatoom
Journal:  IJID Reg       Date:  2022-03-23

2.  Ocular dirofilariasis: a case series of 8 patients.

Authors:  Chris D Kalogeropoulos; Maria I Stefaniotou; Konstantina E Gorgoli; Chrissanthy V Papadopoulou; Chrysavgi N Pappa; Costas A Paschidis
Journal:  Middle East Afr J Ophthalmol       Date:  2014 Oct-Dec

3.  An unusual presentation of lacrimal gland dirofilariasis.

Authors:  Amit Sethi; Vani Puri; Natasha Dogra
Journal:  Indian J Ophthalmol       Date:  2017-07       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.